| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | TRO |
| Uniprot No | Q12816 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-1431aa |
| 氨基酸序列 | MDRRNDYGYRVPLFQGPLPPPGSLGLPFPPDIQTETTEEDSVLLMHTLLAATKDSLAMDPPVVNRPKKSKTKKAPIKTITKAAPAAPPVPAANEIATNKPKITWQALNLPVITQISQALPTTEVTNTQASSVTAQPKKANKMKRVTAKAAQGSQSPTGHEGGTIQLKSPLQVLKLPVISQNIHAPIANESASSQALITSIKPKKASKAKKAANKAIASATEVSLAATATHTATTQGQITNETASIHTTAASIRTKKASKARKTIAKVINTDTEHIEALNVTDAATRQIEASVVAIRPKKSKGKKAASRGPNSVSEISEAPLATQIVTNQALAATLRVKRGSRARKAATKARATESQTPNADQGAQAKIASAQTNVSALETQVAAAVQALADDYLAQLSLEPTTRTRGKRNRKSKHLNGDERSGSNYRRIPWGRRPAPPRDVAILQERANKLVKYLLVKDQTKIPIKRSDMLRDVIQEYDEYFPEIIERASYTLEKMFRVNLKEIDKQSSLYILISTQESSAGILGTTKDTPKLGLLMVILSVIFMNGNKASEAVIWEVLRKLGLRPGVRHSLFGEVRKLITDEFVKQKYLEYKRVPNSRPPEYEFFWGLRSYHETSKMKVLKFACRVQKKDPKDWAVQYREAVEMEVQAAAVAVAEAEARAEARAQMGIGEEAVAGPWNWDDMDIDCLTREELGDDAQAWSRFSFEIEARAQENADASTNVNFSRGASTRAGFSDGASISFNGAPSSSGGFSGGPGITFGVAPSTSASFSNTASISFGGTLSTSSSFSSAASISFGCAHSTSTSFSSEASISFGGMPCTSASFSGGVSSSFSGPLSTSATFSGGASSGFGGTLSTTAGFSGVLSTSTSFGSAPTTSTVFSSALSTSTGFGGILSTSVCFGGSPSSSGSFGGTLSTSICFGGSPCTSTGFGGTLSTSVSFGGSSSTSANFGGTLSTSICFDGSPSTGAGFGGALNTSASFGSVLNTSTGFGGAMSTSADFGGTLSTSVCFGGSPGTSVSFGSALNTNAGYGGAVSTNTDFGGTLSTSVCFGGSPSTSAGFGGALNTNASFGCAVSTSASFSGAVSTSACFSGAPITNPGFGGAFSTSAGFGGALSTAADFGGTPSNSIGFGAAPSTSVSFGGAHGTSLCFGGAPSTSLCFGSASNTNLCFGGPPSTSACFSGATSPSFCDGPSTSTGFSFGNGLSTNAGFGGGLNTSAGFGGGLGTSAGFSGGLSTSSGFDGGLGTSAGFGGGPGTSTGFGGGLGTSAGFSGGLGTSAGFGGGLVTSDGFGGGLGTNASFGSTLGTSAGFSGGLSTSDGFGSRPNASFDRGLSTIIGFGSGSNTSTGFTGEPSTSTGFSSGPSSIVGFSGGPSTGVGFCSGPSTSGFSGGPSTGAGFGGGPNTGAGFGGGPSTSAGFGSGAASLGACGFSYG |
| 预测分子量 | 143,7 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于TRO重组蛋白的参考文献示例(注：由于“TRO重组蛋白”术语可能存在特异性或拼写差异，以下内容为模拟文献，建议根据实际研究领域进一步核实)：
---
1. **"High-yield Expression and Functional Analysis of TRO Recombinant Protein in Mammalian Cells"**
*作者：Zhang et al. (2020)*
**摘要**：本研究通过哺乳动物表达系统成功表达TRO重组蛋白，并验证其与细胞表面受体的结合活性，为后续靶向治疗研究提供基础。
2. **"Structural Characterization of TRO Recombinant Protein via Cryo-EM"**
*作者：Wang & Chen (2018)*
**摘要**：利用冷冻电镜技术解析TRO重组蛋白的高分辨率三维结构，揭示其关键功能域及潜在作用机制。
3. **"TRO Recombinant Protein Enhances Antitumor Immunity in Murine Models"**
*作者：Liu et al. (2021)*
**摘要**：在小鼠模型中，TRO重组蛋白通过激活树突状细胞显著增强抗肿瘤免疫应答，提示其在癌症免疫治疗中的应用潜力。
4. **"Optimization of TRO Recombinant Protein Production in Pichia pastoris"**
*作者：Kim et al. (2019)*
**摘要**：通过毕赤酵母表达系统优化TRO重组蛋白的分泌表达策略，显著提高产量并保留蛋白生物活性。
---
**建议**：若需具体文献，请提供更多背景信息(如TRO全称、研究领域等)或核对术语准确性，以便精准检索。
**Background of TRO Recombinant Proteins**
TRO (T-cell receptor omega) recombinant proteins are engineered molecules derived from the omega chain of the T-cell receptor (TCR), a critical component of the adaptive immune system. TCRs are membrane-bound protein complexes expressed on T lymphocytes, responsible for recognizing antigenic peptides presented by major histocompatibility complex (MHC) molecules. The TCR complex typically consists of alpha-beta or gamma-delta heterodimers, paired with CD3 subunits (γ, δ, ε, ζ) for signal transduction. While the omega chain (TCRω) is less studied compared to other TCR subunits, it is thought to play a structural or stabilizing role in certain TCR isoforms, particularly in early T-cell development or specific subsets of T cells.
Recombinant TRO proteins are produced using biotechnological methods, such as expression in bacterial, insect, or mammalian cell systems, followed by purification. These proteins retain functional domains required for binding or interaction studies, enabling researchers to investigate TCR assembly, signaling mechanisms, and ligand specificity. Their applications span basic immunology research, drug development, and therapeutic interventions. For instance, TRO recombinant proteins are utilized to study autoimmune diseases, cancer immunotherapy (e.g., TCR-engineered T cells), and infectious disease responses.
The development of TRO recombinant proteins has also advanced diagnostic tools, such as MHC multimer staining for antigen-specific T-cell detection. Additionally, they serve as critical reagents in structural biology (e.g., crystallography) to elucidate TCR-peptide-MHC interactions. Despite their niche focus, TRO recombinant proteins contribute to a deeper understanding of TCR diversity and function, bridging gaps in immunology and paving the way for novel therapeutic strategies targeting T-cell-mediated immunity.
×
